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ABSTRACT
An important antibiotic target, DNA gyrase is an es-
sential bacterial enzyme that introduces negative su-
percoils into DNA and relaxes positive supercoils
accumulating in front of moving DNA and RNA poly-
merases. By altering the superhelical density, gyrase
may regulate expression of bacterial genes. The in-
formation about how gyrase is distributed along ge-
nomic DNA and whether its distribution is affected
by drugs is scarce. During catalysis, gyrase cleaves
both DNA strands forming a covalently bound inter-
mediate. By exploiting the ability of several topoi-
somerase poisons to stabilize this intermediate we
developed a ChIP-Seq-based approach to locate,
with single nucleotide resolution, DNA gyrase cleav-
age sites (GCSs) throughout the Escherichia coli
genome. We identified an extended gyrase binding
motif with phased 10-bp G/C content variation, indi-
cating that bending ability of DNA contributes to gy-
rase binding. We also found that GCSs are enriched
in extended regions located downstream of highly
transcribed operons. Transcription inhibition leads
to redistribution of gyrase suggesting that the en-
richment is functionally significant. Our method can
be applied for precise mapping of prokaryotic and
eukaryotic type II topoisomerases cleavage sites in
a variety of organisms and paves the way for future
studies of various topoisomerase inhibitors.
INTRODUCTION
DNA supercoiling accompanies processes that involve un-
winding of double helix, i.e. transcription, replication and
recombination (1–4). Topoisomerases (topos) control the
level of DNA supercoiling, resolve entangled DNA struc-
tures (knots and catenanes), and may take part in genome
compaction (4–6). Depending on the mechanism of their
action, two major types of topo enzymes are distinguished
(7). A type II topo present in bacteria, DNA gyrase, is the
only known enzyme that can introduce negative supercoils
using the chemical energy of ATP hydrolysis (8). Gyrase,
together with another type II topo operating in Escherichia
coli, Topo IV, is indispensable for DNA replication. Cur-
rent view is that Topo IV acts on pre-catenanes forming be-
hind the fork while gyrase is well suited to relax positive
supercoils accumulating in front of the replisome (9,10). In
E. coli, a balance between type I Topo I relaxation activity
and DNA gyrase supercoiling activity is required to achieve
and maintain superhelical density levels optimal for differ-
ent physiological states (11–16).
The distribution of topoisomerases across the chromo-
some is thought to be governed, in part, by transcription-
induced supercoiling. The ‘twin supercoiled-domain model’
proposed by Liu and Wang in 1987 (17) explained the ear-
lier observation that transcription affected supercoiling (18)
and was confirmed experimentally a year later (19). It en-
visions that transcribing RNA polymerase (RNAP) gener-
ates downstream positive supercoils, while the same number
of negative supercoils is formed upstream. DNA gyrase has
an increased affinity for positively supercoiled regions (20)
and, according to the model, relaxes DNA downstream of
the transcription elongation complex, while Topo I, which
prefers negatively supercoiled DNA (21,22), acts upstream.
Recent genome-wide studies using ChIP-Seq in Mycobac-
terium tuberculosis (23) and ChIP-chip in E. coli (24) re-
veal that global distribution of gyrase and Topo I is gen-
erally consistent with the ‘twin supercoiled-domain model’
expectations. Specifically, the Ori-Ter gradient of gyrase
binding (24–26) is thought to correspond to the gradient
of transcription activity, which leads to positive supercoil-
ing neutralization in the E. coli genome during the expo-
nential phase of growth (27). However, it is still unknown
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whether gyrase-binding gradient is the intrinsic property
of the genome in terms of the binding sites location, or is
caused by transcription-mediated supercoiling.
Gyrase preferentially binds some sequences (strong gy-
rase sites, SGSs) irrespective of transcription. The best-
studied Mu SGS is essential for replication of E. coli bac-
teriophage Mu; it allows organization of the integrated vi-
ral genome into a separate topological domain leading to
efficient recombination of aligned prophage ends (28–30).
Genetic analysis of Mu SGS highlighted the importance of
anisotropically flexible right arm for gyrase binding (31,32).
Other SGSs were found in the pSC101 and pBR322 plas-
mids (33,34). Gyrase was also shown to preferentially bind
and cleave bacterial interspersed mosaic elements (BIMEs)
in the E. coli genome (35,36).
DNA gyrase functions as a GyrA2GyrB2 tetramer with
three major interfaces called ‘gates’. The gates can tem-
porarily open, allowing transfer of double-stranded DNA
(Figure 1A). The ‘N-gate’ is formed by the N-terminal
ATP-binding GHKL domains of GyrB; the ‘DNA-gate’
is formed by the C-terminal TOPRIM domain of GyrB
and the N-terminal WHD domain of GyrA, while the ‘C-
terminal’ or ‘exit’ gate is formed by coiled-coiled (CC) do-
mains of GyrA. Being a type II enzyme, gyrase introduces
a double-strand break in the ‘G’ or ‘gate’ segment DNA
bound at the GyrA dimer interface, forming a covalent in-
termediate cleavage complex. Upon the binding of ATP,
the enzyme captures a ‘T’ or ‘transported’ DNA segment
and transfers it through the break in the G segment. The
double-strand break is next religated. The T segment must
be located in cis with the G segment and the bound DNA
must be wrapped around the enzyme forming a positive
node. Wrapping is facilitated by the C-terminal domains of
GyrA (CTDs) (Figure 1A). When the enzyme completes its
cycle, two negative supercoils are introduced into a DNA
molecule (37,38).
In the intermediate cleavage complex catalytic tyrosines
of the GyrA subunits (Tyr122 in E. coli GyrA) with the
help of Mg2+ ions coordinated by the TOPRIM domains
of GyrB attack and cleave the G segment, forming 4-bp 5′-
overhangs covalently linked via phosphodiester bonds to
the tyrosine residues (39,40). Many gyrase inhibitors trap
covalent cleavage complexes leading to accumulation of
double-stranded breaks and, ultimately, cell death (41–44).
Purification of trapped complexes followed by deproteina-
tion and sequencing (or hybridization) of recovered DNA
allows one to analyze the sites of gyrase cleavage (Figure
1B). Earlier such approach was widely used for mapping
of particular cleavage sites (29,33,45,46) and for investigat-
ing relatively short DNA regions in detail (34–36,47,48).
Next-generation sequencing allowed genome-wide analysis:
cleavage maps were generated for Topo IV in E. coli and
Topo IIA in human cells (49,50). As a consequence of trap-
ping, several amino acid residues from topoisomerase ac-
tive site remain linked to the 5′-ends of nucleic acid frag-
ments after proteolytic treatment, resulting in poor adapter
ligation efficiency (49). To overcome this challenge, we de-
veloped a procedure, which we name Topo-Seq, that em-
ploys single-strand DNA sequencing protocol (51) to ob-
tain information on DNA strands that remain free within
the cleavage complexes. Since cleavage by gyrase gener-
ates 4-bp 5′-overhangs, application of our procedure re-
sults in 4-bp gaps in coverage at the cleavage sites, allow-
ing their precise identification. We used Topo-Seq to gen-
erate whole-genome maps of gyrase cleavage events in E.
coli induced by three different gyrase poisons: closely re-
lated ciprofloxacin/oxolinic acid and microcin B17. The lat-
ter has a different mechanism of action, giving us an op-
portunity to cross-validate the results and exclude possible
drug-specific artifacts. We show that global gyrase distribu-
tion along the genome is governed by two factors: transcrip-




Escherichia coli DY330 GyrA-SPA (W3110 lacU169
gal490 cI857 (cro-bioA) gyrA-SPA) was purchased
from Dharmacon. Escherichia coli DY330 GyrA-SPA Mu
SGS (DY330 gyrA-SPA (dcuC-crcA)::(cat-Mu SGS)) con-
structed for this study (strain construction details are de-
scribed in one of the following sections of Materials and
Methods) were used for Topo-Seq and Topo-qPCR ex-
periments and MIC estimation. Both strains have gyrA
gene fused with C-terminal SPA affinity tag for effi-
cient purification of GyrA subunits. For Topo-Seq ex-
periments bacteria were inoculated from glycerol stocks
stored at −80◦C on agar plates containing corresponding
antibiotics (kanamycin 50 g/ml for DY330 GyrA-SPA
and kanamycin 50 g/ml, chloramphenicol 15 g/ml for
DY330 GyrA-SPA Mu SGS). Plates were incubated at 32◦C
for 24–32 h, then stored at 4◦C for 1 week. Liquid cul-
tures were started from single isolated colonies and culti-
vated in 2YT medium at 32◦C with shaking (180rpm). E.
coli BW25113 (52) was used for microcin B17 production
as described in (53). Escherichia coli NEB5 was used for
plasmids production for in vitro experiments.
Microcin B17 purification
Escherichia coli BW25113 was transformed with pBAD-
mcbABCDEFG plasmid and night culture was inoculated
with one isolated colony. One liter of 2YT media was inoc-
ulated with 1/100 volume of the overnight culture. When
the culture reached OD600 = 0.6–0.8, mcb operon expres-
sion was induced by addition of arabinose up to 1 mM.
Cultivation was continued for 18–20 h on 37◦C with shak-
ing on 180 rpm. Cells were pelleted by centrifugation, then
resuspended in 40 ml of 100 mM acetic acid/1 mM EDTA
and boiled for 15 min. The clarified supernatant was ap-
plied onto 1 g C18 HyperSep cartridge (Thermo Scientific)
pre-equilibrated with 0.1% trifluoroacetic acid (TFA). The
cartridge was extensively washed with 0.1% TFA followed
by 10% acetonitrile (ACN) in 0.1% TFA. The microcin B17-
containing fraction was eluted in 30 ml 30% ACN in 0.1%
TFA and vacuum dried (GeneVac). The resulting precipi-
tate was dissolved in dimethyl sulfoxide (DMSO) and ap-
plied onto Phenomenex Luna C18 high-performance liq-
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Figure 1. DNA gyrase structure and Topo-Seq procedure. (A) DNA gyrase structure with gyrase domains (GHKL, TOPRIM, WHD, CC, CTD) indicated.
(B) Topo-Seq workflow: (i) Schematic illustration of DNA gyrase on DNA plectonemes; (ii) A gyrase-DNA complex trapped with an inhibitor, here
quinolone-like (red stars); (iii) C-terminal SPA tag is recognized by M2 antibodies and used to precipitate gyrase-bound fragments; (iv) Deproteinized
DNA fragments have blocked 5′-ends; (v) Resulting signals visualized.
0.1% TFA) in 10% DMSO/0.1% TFA. Elution was per-
formed with linear gradient of ACN (from 0% to 50% ACN
in 30 min) in 0.1% TFA. Microcin B17 was eluted between
12 and 16 min, individual peaks were collected. Fractions
obtained were merged and dried in vacuo. Lyophilized pow-
der was dissolved in DMSO and stored at −20◦C. Concen-
tration of the microcin B17 was determined spectroscopi-
cally as described previously (54).
E. coli DY 330 gyrA-SPA Mu SGS strain construction
349-bp DNA fragment containing strong gyrase binding
site from bacteriophage Mu (Mu SGS) was amplified from
pMP1000 plasmid (45) (a gift of P. Higgins) using Mu G F
and Mu G R primers. cat gene was amplified from pKD3
plasmid (52) with G cat Mu and cat Mu R primers (Sup-
plementary Table S2). Fragments were joined by overlap
PCR using G cat Mu and Mu G R primers. Resulting cas-
sette was inserted into intergenic region between dcuC and
crcA genes using recombination techniques described else-
where (55). Successful insertion was confirmed by PCR and
whole genome sequencing.
Minimal inhibitory concentration (MIC) measurement
MICs were determined by microdilution method in 96-well
plates in liquid LB according to CLSI guidelines (M07-
A10). Inoculum suspensions were prepared by dilution of
night cultures grown in LB up to 1–5 × 105 CFU/ml. Plates
were incubated 18–24 h on 37◦C, MIC recorded as minimal
concentration of antibiotic that completely inhibit bacterial
growth.
ChIP with DNA gyrase poisons as stabilizing agents (Topo-
Seq step I)
One milliliter of overnight culture was prepared for E.
coli DY330 GyrA-SPA or E. coli DY330 GyrA-SPA Mu
SGS by inoculating 2YT medium supplemented with an-
tibiotics (kanamycin 50 g/ml for DY330 GyrA-SPA
and kanamycin 50 g/ml, chloramphenicol 15 g/ml for
DY330 GyrA-SPA Mu SGS) with cells from a single colony.
The culture was cultivated at 32◦C with shaking (180 rpm)
and then inoculated into 100 ml of 2YT without antibi-
otics and cultivation was continued at 37◦C and shaking
until culture reaching mid-logphase (OD600 = 0.6–0.8). At
this point, the culture was bisected and DNA gyrase poison
(0.9 or 10 M ciprofloxacin, 120 M oxolinic acid, 10 or
50 M microcin B17––see Supplementary Table S1 for de-
tails) was added to the first half (+A samples), while the
second served as a control (–A samples). Cultures (+A and
–A) were incubated at 37◦C with shaking for additional
15 min, then cells were pelleted by centrifugation at 10◦C
(4500 g) and resuspended in 10 ml of TES buffer (10 mM
Tris–Cl pH 7.5, 1 mM EDTA, 250 mM NaCl). Washing
procedure was repeated twice to remove all traces of cul-
turing medium. Washed pellets were resuspended in 1 ml
of TESS buffer (10 mM Tris–Cl pH 7.5, 1 mM EDTA,
250 mM NaCl, 0.02% SDS, 0.2% Tween-20) with addition
of protease inhibitors cocktail (cOmplete ultra EDTA free,
Roche) and RNAse A (Thermo Scientific). Resulting sus-
pensions were sonicated with parameters optimized to ob-
tain DNA fragments between 200 and 700 bp (24 cycles
of 10 sec ON/20 sec OFF, 65% power, SONOPULS HD
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100 l of ANTI-FLAG® M2 affinity gel (Sigma-Aldrich)
was added. Immunoprecipitation was performed for 1.5–2
h at room temperature with moderate mixing, then affin-
ity gel was washed 4 times (two times with 1 ml of TESS
buffer, once with 1 ml of TES buffer, and once 1 ml of TE
buffer). For proteolysis, affinity gel obtained after the last
wash step was diluted with TES buffer up to 200 l, pro-
teinase K (Sigma-Aldrich) was added (0.5 mg/ml) and sam-
ples were incubated at 55◦C for at least 3 h. After this step
samples were centrifuged (2 min, 2000g at room tempera-
ture) and DNA was extracted from resulting supernatant
with phenol/chlorophorm method followed by ethanol pre-
cipitation. Mock controls (–IP) were made both for +A and
for –A: for this, 100 l aliquots of lysates obtained after
sonication were deproteinized and DNA was purified as
described before. The procedure described gives a quartet
of samples (+A+IP, +A-IP, -A+IP, –A-IP), where +A-IP, –
A+IP and –A-IP serves as controls for gyrase poison action
and immunoprecipitation.
DNA sequencing (Topo-Seq step II), reads trimming and
alignment
Sequencing libraries were prepared with Accel NGS 1S kit
(Swift Bioscience) from DNA obtained in step I proce-
dure, according to the manufacturer’s protocol. Sequenc-
ing was performed on Illumina NextSeq platform (150 bp
paired-end reads) at A.N. Belozersky Research Institute of
Physico-Chemical Biology MSU. Combination of gyrase
poison-mediated ChIP procedure (Step I) and specific se-
quencing libraries preparation step (Step II) was named by
us a Topo-Seq technique. For each antibiotic Topo-Seq was
performed in triplicate.
Reads were aligned to the E. coli W3110 Mu SGS genome
(E. coli W3110 genome with the insertion of cat-Mu SGS
cassette may be downloaded from GEO: GSE95567) using
BWA-MEM (56). BAM files were prepared with Samtools
(57) and visualized in IGV (58).
Coverage normalization and GCSs-calling procedure
For each position in the genome a number of 3′-ends (N3E)
and 5′-ends were counted based on reads alignments stored
in SAM file. Obtained values were divided by the total
amount of reads aligned and multiplied by the lowest value
across samples forming the quartet. Additional normaliza-
tion was performed to get rid of the bias in the coverage
depth across the genome: due to active replication, there
is a significant difference in the total amount of DNA be-
tween origin of replication and terminators area. For this
purpose, N3E values of +A+IP sample were divided by cor-
responding N3Es of +A-IP control and N3Es of –A+IP
sample were divided by N3Es of –A-IP control (all sam-
ples originate from the same quartet). N3Es of +A-IP and
–A-IP controls were preliminarily smoothed using 200 kb
sliding window. In resulting pairs of samples (+A+IP norm
and –A+IP norm) gyrase cleavage sites (GCSs) were called
if values in i and i + 5 positions in +A+IP norm sample
both exceed the right confident interval value calculated
based on the appropriate values in –A+IP sample (Audic
and Claverie statistical test from (59), P-value < 0.05). As
Topo-Seq was performed for each antibiotic in triplicate,
GCS was called reliable if it was identified in at least two
biological replicas. Only reliable GCSs sets were used for
further analysis.
qPCR validation of Topo-Seq (Topo-qPCR)
qPCR was performed to estimate the enrichment of DNA
at specific loci after Step I (Mu SGS, rRNA A DS, ccmH
and rRNA A US) and validate data obtained with Topo-
Seq (primers listed in Supplementary Table S2). Step I of
the procedure followed by qPCR was named Topo-qPCR.
Gyrase motif identification
DNA sequences were extracted from E. coli W3110 Mu
SGS genome as a 130 bp vicinity of identified GCSs’ po-
sitions. Therefore, all the sequences are centered relative
to the DNA-gyrase cleavage sites and sequences sets can
be processed as multiple alignments: nucleotide frequencies
were counted within formed columns giving position prob-
ability matrix (PPM) visualized with Python Matplotlib
package (60). The degenerate GC% motif was obtained sim-
ilarly by calculating the frequency of G or C in the columns
of the alignment. Logos were calculated with WebLogo for
the same sets of DNA sequences (61). Motif visualization
and Logos were made for each Topo-Seq condition inde-
pendently. ‘Combined’ gyrase motif was constructed using
sequences obtained from Cfx, Micro and Oxo Topo-Seq
experiments. For each antibiotic top 732 GCSs having the
highest N3E values were taken, resulting in a set containing
1828 sequences that was used for PPM and Position Weight
Matrix construction. Antibiotic-specific bias was removed
for positions most influenced by antibiotics (0–3 bp; in coor-
dinates we use, cleavage takes place between positions -1/0
and +3/+4) in the intermediate PPM by changing corre-
sponding values with a baseline frequencies of nucleotides
observed in a E. coli W3110 genome. PPM can be found
in Supplementary Table DS10. To find potential DNA gy-
rase binding sites, sequences of interest were scanned with
final PWM in forward and reverse-complement forms. For
the particular position, a maximum between values ob-
tained for both strands was specified and referred further as
“score”. PWM construction and sequences scanning were
performed with Bio.motifs from Biopython package (62).
3D modeling
DNA model (B-form, 10.7 bp/turn, bend angle 210◦) was
constructed for 43 bp fragment of the consensus sequence
(–63:–21 or 24:66 regions within periodic areas) using 3D-
DART web service (63). The model was manually docked
with the structure of E. coli DNA gyrase CTD (1zi0 (64)) in
PyMOL (PyMOL Molecular Graphics System, Version 1.8
Schrödinger, LLC).
Rif Topo-Seq and Rif Topo-qPCR with transcription de-
pressed cells
Topo-Seq and Topo-qPCR experiments were performed as
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pretreated with RNA-polymerase inhibitor rifampicin (122
M) for 15 min to stop transcription (65) before addition
of DNA gyrase poison (10 M ciprofloxacin).
Estimation of E. coli genes transcription level
3′-end RNA-Seq data was taken from publically available
dataset (GEO dataset GSE95567) for E. coli K-12 DH10B
cultivated under similar conditions (rich medium, 37◦C,
grown until OD600 ∼0.3) (66). Transcription level of a par-
ticular gene was calculated as an average sequencing depth
of this gene.
Determination of chromosomal macrodomains boundaries in
E. coli W3110 Mu SGS
Macrodomains determined for E. coli MG1655 by Valens
et al. (67) were applied to E. coli W3110 Mu SGS with mod-
ifications caused by Ori region inversion in W3110 strain in
comparison to MG1655 as discussed in Duigou and Boc-
card (68). Differences between macrodomains of the two
strains summarized in Supplementary Table DS2.
DNA gyrase in vitro assays
133 bp DNA fragments (Supplementary Table S2) for in
vitro experiments were ordered in GenScript as pUC19
clones (HincII site). Plasmids were routinely obtained from
E. coli NEB5 (New England Biolabs) and purified using
GeneJET Plasmid Miniprep Kit (Thermo Scientific). For
EMSA and competition assays DNA fragments were PCR
amplified using pUC19 for and pUC19 rev primers (Sup-
plementary Table S2) and purified with Gel Extraction and
DNA Cleanup Micro Kit (Thermo Scientific).
For electrophoretic mobility shift assay (EMSA) 25 nM
of DNA fragments (Mu SGS, Consensus sequence or
Scrambled consensus) were mixed with different amounts
of reconstituted gyrase (0, 1, 2.5, 5 or 10× excess) holoen-
zyme (GyrA2GyrB2), incubated for 30 min at 25◦C and run
on 5% polyacrylamide gel in TBM buffer (90 mM Tris-
borate, pH 7.5, 4 mM MgCl2). After the run gels were
stained with SYBR Gold for 20 min and visualized under
UV light.
For ATP-independent relaxation assay purified plas-
mids (∼9.5 nM) were mixed with gyrase holoenzyme
(GyrA/GyrB, ∼7.5 nM) in a reaction buffer (35 mM Tris–
HCl pH 7.5, 24 mM KCl, 4 mM MgCl2, 0.1 mg/ml BSA,
6.5% glycerol, 2 mM DTT) and incubated at 37◦C for indi-
cated times (0, 30, 60 min). Reactions were stopped with 1
volume of chloroform:isoamyl alcohol 24:1 and 1 volume of
STEB (10 mM EDTA, 40% sucrose, 0.5 mg/ml bromophe-
nol blue, 100 mM Tris–HCl pH 7.5). Aqueous layer was col-
lected and topoisomers were separated in 1% TAE agarose
gel with subsequent ethidium bromide staining.
For supercoiling, ∼9.5 nM of relaxed plasmids were com-
bined with DNA gyrase holoenzyme (∼2.3 nM) in a reac-
tion buffer (35 mM Tris–HCl pH 7.5, 24 mM KCl, 4 mM
MgCl2, 0.1 mg/ml BSA, 6.5% glycerol, 2 mM DTT, 1.8
mM spermidine, 1 mM ATP) and incubated at 37◦C for in-
dicated times (0, 30, 60 min). Reactions were stopped and
products were analyzed as described for ATP-independent
relaxation assay. Supercoiling assays in the presence of com-
petitor were done as above but 4.5 nM gyrase holoenzyme
was incubated with ∼6 nM relaxed pBR322 substrate (In-
spiralis) for 30 min at 37◦C in the presence of required
amounts of linear competitor.
For ATP-dependent relaxation, 80 nM of
GyrA592GyrB2 was mixed with 9.3 nM of purified
plasmids in a reaction buffer (35 mM Tris–HCl pH 7.5, 125
mM KCl, 8 mM MgCl2, 0.36 mg/ml BSA, 6% glycerol,
5 mM DTT, 1.4 mM ATP) and incubated at 37◦C for
indicated times (0, 30, 60 min). Reactions were stopped and
products were analyzed as described for ATP-independent
relaxation assay.
Quantification and statistical analysis
During GCSs-calling procedure Audic and Claverie test
(59) was used to estimate enrichment significance with
P-value <0.0025 as a threshold (custom Python script).
Overrepresentation of GCSs in macrodomains, BIME-2
elements and downstream regions of rRNA operons was
shown using binomial test (Supplementary Tables DS2,
DS3, and DS7A). Statistical analysis of the number of
GCSs in upstream, beginning, end, and downstream re-
gions of genes and operons depending on their transcription
status also based on binomial test (Supplementary Figure
DS8, Supplementary Figure S13). Binomial test was used
to estimate the number of GCSs that colocalize with top-
scored genome sites (Supplementary Table DS4B). Bino-
mial test with P-value cutoff = 0.001 was used to estimate
statistically fluctuations in the numbers of GCSs over the E.
coli genome (Figure 3, Supplementary Figure S11, custom
python script). Fisher exact test was used to compare the
numbers of GCSs in upstream, body, and downstream re-
gions of rRNA operons between Cfx and RifCfx conditions
(Figure 6C, custom Python script). To test the enrichment
in the number of GCSs that fall into BIME-2 and which
increase their N3E values after treatment with rifampicin,
and to test the enrichment in the number of GCSs down-
stream of rRNA operons which decrease N3Es after ri-
fampicin treatment, we used binomial test (Figure 6D, cus-
tom Python script). To identify significant bias in nucleotide
frequencies during gyrase motif construction we used bi-
nomial test (Supplementary Figure S4, Supplementary Fig-
ure S5A, custom Python script). To identify associations of
GCSs with TADs and sites of spontaneous mutations bino-
mial test was used (Supplementary Table DS8, DS9, custom
python script). Topo-qPCR experiments were performed in
triplicate (Supplementary Table DS1), enrichment compari-
son was performed with t-test (Figure 6A, custom R script).
T-test was used to compare score for BIME-2 regions, H-
NS occupied areas, and downstream regions of different
TUs sets (Supplementary Table DS7B) with E. coli genome
score (custom python script). t-test was used to estimate de-
viation of score values of GCSs sets associated with TUs
downstream regions (Supplementary Table DS7B). Exact
conditional test for Poisson-distributed values (69) was used
to estimate the deviation of N3E values for GCSs sets asso-
ciated with TUs downstream regions (Supplementary Ta-
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to estimate the significance of overlap between MatP and
MukB binding sites (Supplementary Table DS6A).
RESULTS
Topo-Seq allows precise localization of gyrase cleavage sites
To efficiently sequence purified DNA fragments with co-
valently linked gyrase peptides, we applied a single-strand
paired-end sequencing protocol (see Methods) to get rid
of modified DNA chains at the library preparation step
(Supplementary Figure S1). Thus, only free chains with 3′-
ends directed towards the gyrase catalytic site are being
sequenced, resulting in a specific structure of enrichment
peaks at GCSs. Each of them should have a characteris-
tic bimodal shape with a sharp 4-bp gap in the middle. Se-
quences to the left of the gap should align in a forward ori-
entation with the GCS; their 5′-ends should vary, while 3′-
ends should be identical and form the left ‘wall’ of the cen-
tral 4-bp gap. Sequences to the right of the gap should sim-
ilarly align in reverse orientation.
To validate Topo-Seq, we constructed an E. coli strain
with the Mu SGS inserted into a non-essential region of
the genome. Exponentially growing cells were treated with
several DNA gyrase inhibitors - ciprofloxacin (Cfx), mi-
crocin B17 (Micro), and oxolinic acid (Oxo) and subjected
to Topo-Seq. While a weak signal was observed in con-
trol untreated cells at Mu SGS, in the presence of the in-
hibitors there was a dramatic increase in the abundance of
intermediate complexes, resulting in a strong signal (Fig-
ure 2A). Concentrations of poisons used in Topo-Seq were
chosen to be well above experimentally determined minimal
inhibitory concentrations (MICs) for our strains (Supple-
mentary Table S1). The shape of a signal at Mu SGS fully
matched the expectations based on gyrase catalytic mech-
anism and the sequencing protocol used. The positions of
the 4-bp gap ‘walls’ coincided with cleavage positions ob-
served in previous biochemical studies of gyrase complexes
trapped on Mu SGS in vitro (31,45,46) (Figure 2B). Thus,
our procedure allows for accurate single-nucleotide identi-
fication of GCSs in vivo.
Thousands of DNA gyrase cleavage sites are distributed
throughout the E. coli genome
We next investigated the global distribution of GCSs in cells
treated with gyrase poisons. We used the hallmark 4-bp gaps
between 3′-ends of Topo-Seq enriched DNA fragments to
develop an automatic GCS-calling procedure. Plotting the
number of 3′-ends (N3E) allowed us to globally identify
pairs of enriched positions (gap walls) separated by 4-bp
gaps. We interpret these signals as gyrase trapping sites; the
heights of gap walls provide an estimate of the relative num-
ber of gyrase binding events that initiate the strand passage
step at a particular site.
GCSs were detected as significantly enriched signals (sta-
tistical test from (59), P-value < 0.0025) during the two-
step normalization procedure (see STAR Methods) and
have passed additional filtering as being shared between at
least two out of three biological replicas that were made
for each gyrase inhibitor. In total, 4635 GCSs distributed
throughout the genome were identified in Cfx-treated cells,
5478 in Oxo-treated, and 732 in Micro-treated cells (Supple-
mentary Table S1). 41% of GCSs identified in the presence
of Cfx are shared with Oxo set. The level of GCSs com-
mon for Micro and Cfx, or Micro and Oxo-treated cells
is lower (33% and 23% of Micro GCSs, respectively), con-
sistent with higher degree of similarity between Cfx and
Oxo compared to a non-quinolone poison (Figure 3A). We
found that GCSs revealed simultaneously by several drugs
tend to have stronger signals (Supplementary Figure S17).
We also found that the number of GCSs depends on the
concentration of the poison used: for example, using 30–
50-fold excess of Cfx over MIC we got 50–250 GCSs, while
300–600-fold excess gave 6000–7000 GCSs. Similarly, a 5-
fold increase in Micro concentration resulted in the rise of
the number of GCSs from 500–700 up to more than 3000
(Supplementary Table S1). Thus, the relatively low number
of GCSs observed with Micro (732 GCSs at 30–40× MIC)
is likely due to lack of saturation. Interestingly, compared
to Oxo, Cfx is a much more effective cell growth inhibitor.
Yet, judging by number of GCSs revealed by Topo-Seq, 120
M Oxo (120–180× MIC) traps gyrase significantly more
effectively than 10 M Cfx (300–600× MIC). These obser-
vations seem to suggest that gyrase capture and subsequent
cell death may be mediated by different processes. Indeed,
differences in killing mechanisms between oxolinic acid and
newer generations of quinolones have been reported (70).
A comparison of GCSs detected in strains with or with-
out Mu SGS revealed no noticeable differences (apart from
the expected strong gyrase enrichment at Mu SGS in the for-
mer strain) indicating that insertion of Mu SGS does not
significantly affect genome-wide gyrase distribution (Sup-
plementary Figure S2).
When regions flanking Mu SGS and another strong GCS
(site downstream of rRNA A operon) identified by our pro-
cedure were tested by Topo-qPCR (for Cfx), enrichment
was detected, and extent of this enrichment corresponded
to levels of Topo-Seq signals. In contrast, no enrichment
was observed during qPCR with primers specific for con-
trol sites where no gyrase cleavage was detected by Topo-
Seq (Pearson’s correlation: 0.94) (Supplementary Figure S3,
Supplementary Table DS1). We conclude that our peak call-
ing procedure is robust and reflects the in vivo positioning
of gyrase intermediates trapped by the inhibitor.
The analysis of the E. coli chromosome architecture
(67,68) revealed the presence of large topologically indepen-
dent macrodomains located around the replication origin
and terminator region (Ori and Ter macrodomains, respec-
tively). Ter is flanked with Left and Right macrodomains,
separated from Ori by the left and right non-structured re-
gions of the chromosome (NSleft and NSright, correspond-
ingly). We observed statistically significant overrepresenta-
tion of GCSs in NSleft and Ori and underrepresentation
in Ter and Left (binomial test, P-values are <1e-3) (Fig-
ure 3B and Supplementary Table DS2, Supplementary Fig-
ure S11). This pattern could not have been due to intensive
DNA replication in actively dividing cells since the two-step
normalization procedure used for GCSs calling involved
normalization for local copy number/sequencing depth.
Topo-Seq data was compared with available ChIP-chip
gyrase binding data (24). Despite the differences between
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Figure 2. Signal structure at the strong gyrase binding site from bacteriophage Mu (Mu SGS). (A) Profiles of the number of 5′- and 3′-ends (N5E and N3E
correspondingly) are shown in black. Total coverage depth (Depth) is in blue and coverages for DNA fragments that were aligned in forward and reverse
orientations (F DNAs and R DNAs correspondingly) are in red and sky blue respectively. Tracks height (depth) are shown in brackets. The data visualized
in IGV (58). (B) Close-up of the cleavage site. Coverage depth around the site is shown as a grey track, local sequence lies below. Cleavage sites known
from the existing literature are shown (31,45,46).
Figure 3. Comparison of GCSs sets observed with Cfx, Micro, and Oxo. (A) Venn diagram representation of the relations between GCSs sets obtained
with different gyrase poisons. (B) General distribution of poison-mediated GCSs revealed by Topo-Seq. E. coli W3110 MuSGS genome is divided into 10
non non-overlapping bins, the height of the bars indicates the number of GCSs in a particular genome region. Area between 0.0005 and 0.9995 quantile
values (distribution of the number of GCSs in a bin set as binomial) are shown in light gray, so bars that fall out of this zone have a statistically significant
deviation from a value expected for the uniform distribution. NSRight––right non-structured region; Right––right macrodomain; Ter––terminator domain;
Left––left macrodomain; NSLeft – left non-structured region; Ori––origin domain. Macrodomains set as in (68).
we found a significant positive correlation between both
datasets and a very similar distribution of signals over the
E. coli genome (Supplementary Figure S15). Thus, gyrase
binding and cleavage are likely to be connected, addition-
ally validating the Topo-Seq methodology.
DNA gyrase has an extensive and degenerate binding motif
Single-nucleotide resolution GCS mapping allowed us to di-
rectly look for potential sequence preferences of the gyrase
in antibiotic-treated cells. Aligning of sequences flanking
the positions of GCSs revealed a significant deviation from
random frequencies of nucleotides indicating the presence
of a potential motif. When the obtained frequency matrix
was converted to GC% (see Materials and Methods for de-
tails), similar 130-bp degenerate pattern was observed for
signals obtained from cells treated with each of the gyrase
poisons tested (Figure 4A, Supplementary Figure S4). The
pattern is symmetrical with respect to the cleavage sites,
which are located between –1/0 and +3/+4 positions of
the motif. We refer to this pattern as the ‘gyrase motif ’.
It consists of a central (from –16 to 19 bp) part contain-
ing the cleavage site and two flanking (from –63 to –17 bp
and from 20 to 66 bp) regions, each with periodic (10.75
bp) changes in GC% resembling the binding pattern of eu-
karyotic nucleosomes (71) (see Supplementary Figure S5).
Analysis of calculated DNA geometry for GCSs sequences
using GBshape database (72) revealed noticeable deviations
for such parameters as helix twist, propeller twist, and mi-
nor groove width (Supplementary Figure S14). This obser-
vation may indicate that DNA recognition by the enzyme
occurs through indirect readout (73).
The only significant differences between motifs obtained
with different inhibitors were observed at the cleavage site
(Figure 4B). GCS motifs obtained with Cfx and Oxo-
treated cells confirmed the well-established tendency of
quinolones to intercalate and facilitate scission before gua-
nine residues (34,74,75). In contrast, this pattern was not
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Figure 4. DNA gyrase has a binding motif revealed with a range of poisons: Cfx, Micro, and Oxo. (A) DNA sequences under GCSs were extracted and
aligned; resulting motif, shown as a plot of GC content, has a central region (–16:19 nt) around the cleavage site, and two periodic regions (–63:–17 and
20:66 nt). (B) Logo representation of motif ’s central part around cleavage site. In the coordinates chosen, DNA gyrase cleaves forward chain between -1
and 0 and reverse chain between 3 and 4 bp (cleavage events are indicated with arrows).
mode of interaction with gyrase and/or DNA (76), leading
to a different consensus in the central part of GCS. This dif-
ference in cleavage preferences may explain a poor overlap
between the Micro and quinolones GCSs sets (Figure 3A).
When sequences under the GCSs were screened for overrep-
resentation of known motifs with Tomtom (77), none were
detected, suggesting that gyrase trapping is independent of
other DNA binding proteins.
Gyrase activity correlates with sequence properties
To remove antibiotic-specific biases from the gyrase motif,
the frequency values for central positions most affected by
antibiotics (0–3 bp) were made equal to baseline nucleotide
frequencies of the E. coli genome (resulting position fre-
quency matrix and consensus sequence can be found in Sup-
plementary Table DS10). The resulting position-weight ma-
trix corresponding to a ‘combined’ gyrase motif was used to
scan the genome of bacteriophage Mu and the pBR322 and
pSC101 plasmids. As expected, previously known strong
gyrase sites from Mu, pSC101 and pBR322 (33,34,46) were
identified as having the highest scores (Supplementary Ta-
ble DS4A). When the genome of E. coli DY330 Mu SGS
was scanned, Mu SGS had the third highest score. Five out
of 13 highest scoring E. coli sites were among the GCSs
identified by Topo-Seq, a highly significant (binomial test,
P-value: 8.4e–14) overrepresentation. In addition, for 8 out
of 13 highest scoring sites, there was a total of 27 GCSs
within 5 bp of their central regions (Supplementary Table
DS4B) providing independent support for the relevance of
the motif (binomial test, P-value: ∼0) and suggesting some
flexibility of the cleavage sites within the motif.
Analyzing the predictive power of gyrase motif score, we
found that GCSs located in sequences with higher scores
tend to have higher N3E values (Supplementary Figure
S6), an evidence that gyrase activity depends on DNA sub-
strate sequence composition. Correlations between N3E
and score are small, but statistically significant for all Topo-
Seq experiments (Pearson’s correlation: 0.22, 0.15 and 0.23
for Cfx, Micro and Oxo respectively with P-values < 4.3e–
5). N3E and score values for GCSs revealed by more than
one poison are higher (Supplementary Figure S17) mean-
ing that 149 GCSs reproduced in experiments with all
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Figure 5. DNA gyrase behavior depends on a DNA substrate gyrase
binding score. (A) EMSA analysis of DNA gyrase binding with 133
bp fragments; fragments scores are showed above the pictures; molar
gyrase/DNA ratio is indicated under the lanes. SC––scrambled consen-
sus, C––consensus. (B) Time-course of gyrase supercoiling of pUC19
plasmids harboring indicated 133 bp fragments; RE––relaxed plasmid,
NSC––negatively supercoiled plasmid. 1––scrambled consensus, 2––Mu
SGS, 3––consensus. (C) Time-course of ATP-independent relaxation of
pUC19 plasmids harbouring indicated 133 bp fragments. (D) Time-
course of ATP-dependent relaxation of the same plasmids by truncated
GyrA592GyrB2 gyrase lacking CTD.
The DNA gyrase consensus sequence strongly binds the en-
zyme and inhibits its activity in vitro
To test the observations that specific properties of DNA
sequence expressed in the terms of score can explain ele-
vated gyrase activity (estimated as a number of GCSs or
N3E value) at a particular locus, we performed in vitro ex-
periments with a set of 133 bp synthetic DNA sequences
having different degree of similarity to the gyrase bind-
ing motif: a consensus sequence (calculated score 37), Mu
SGS (calculated score = 14.3) and scrambled consensus
(score = 2.5) (Supplementary Table S4). As can be seen
from Figure 5A, affinities of DNA fragments for gyrase
were roughly proportional to their scores in the EMSA as-
say. Linear DNA fragments encompassing Mu SGS and
consensus sequence but not scrambled consensus, inhib-
ited supercoiling of pBR322 plasmid by DNA gyrase when
added as competitor DNA (Supplementary Figure S12).
To more directly look at gyrase activity, we investigated
ATP-dependent supercoiling and ATP-independent relax-
ation of pUC19-based plasmids carrying cloned fragments
described above by DNA gyrase. Surprisingly, the super-
coiling and relaxation efficiency of plasmids was inversely
related to cloned insert score (Figure 5B and C): DNA gy-
rase processed substrates carrying consensus sequence sig-
nificantly slower than substrates with scrambled consensus
or even Mu SGS. In contrast, ATP-dependent relaxation
of plasmids by GyrA59/GyrB gyrase mutant lacking CTD
proceeded at comparable rates (Figure 5D). Taking into ac-
count that CTDs are crucial for DNA wrapping around the
enzyme and supercoiling (78,79) we propose that CTDs rec-
ognize the phased bending signals in the ‘arms’ of the motif
and that strong interactions between DNA and CTDs may
inhibit structural transitions required for the catalytic reac-
tion.
Gyrase is attracted to the regions downstream of transcribed
loci
Based on the ‘twin-domain model’ and the fact that gy-
rase prefers positively supercoiled DNA to act upon, we ex-
pected the enzyme to be preferentially found downstream
of transcribing RNAP (17,20). Whole-genome analysis re-
vealed that in general less GCSs associate with poorly tran-
scribed transcription units (TUs) than with highly tran-
scribed ones (binomial test, P-value ∼0), as has been also
observed in M. tuberculosis (23). We have screened the
highly transcribed loci for their association with GCSs and
found that cleavage sites significantly accumulate in ex-
tended downstream regions of active TUs (Supplementary
Figure S8, Supplementary Figure S13). The enrichment is
most noticeable for rRNA operons, which have the highest
transcription rate (80) (Supplementary Table DS7A).
To experimentally test whether transcription affects the
gyrase distribution, we treated cells with RNAP inhibitor
rifampicin (Rif) before Cfx-mediated gyrase trapping (the
procedure further referred as RifCfx). While the overall
number of cleavage sites dropped twofold after Rif treat-
ment (4635 for Cfx versus 2355 for RifCfx, Figure 6B) their
average strength (measured as N3E value) and sequence
specificity (measured as gyrase binding score value) slightly
increased (Supplementary Figure S7). Rifampicin did not
affect either overall shape of gyrase motif, or local cleavage
properties characteristic of Cfx (Supplementary Figure S9).
At the same time, the global gyrase gradient became altered
and less pronounced (Supplementary Figure S11B). Most
notably, Rif eliminated both the accumulation of GCSs in
the downstream regions of rRNA operons (Figure 6C) and
avoidance of poorly transcribed TUs (Supplementary Fig-
ure S8B). The GCSs which remained downstream of rRNA
operons decreased their signals (Figure 6A and D). In con-
trast, signals from some other sites, potentially not directly
related to transcription intensity, for example GCSs located
in BIME-2 regions, were increased in the presence of Rif
(Figure 6D). Overall, we conclude that transcription inhibi-
tion with rifampicin leads to significant relocation of active
gyrase, suggesting that transcription is a strong factor that
attracts gyrase to downstream DNA.
GCSs are overrepresented in a subset of BIME-2 sequences
We found significant overrepresentation of GCSs in BIME-
2 elements in full agreement with previous experiments (36)
(binomial test, P-value ∼0 for Cfx, 3e–4 for Micro, and 1e–
9 for Oxo). In particular, BIME-2 located between sucC
and sucB and between tldD and yhdP genes house multi-
ple GCSs (Supplementary Table DS3). Closer look revealed
that gyrase much more frequently cleaves y-type than z2-
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Figure 6. Transcription facilitates gyrase activity. (A) Enrichment observed at several genomic sites by Topo-qPCR for Cfx and RifCfx (data for three
replicas). Error bars constructed as ±2 standard errors, P-values for t-test for means are indicated above the bar pairs. (B) Venn diagram showing overlap of
Cfx and RifCfx GCSs sets. (C) GCSs relocation from downstream regions of rRNA operons when transcription is inhibited with rifampicin. Enrichment
in the number of GCSs, which is a ratio of the number of observed GCSs to the number of expected GCSs (statistic––Fisher exact test), is plotted. (D)
GCSs shared between Cfx and RifCfx sorted by ratio of their N3E values. GCSs that fall in 5 kb downstream regions of rRNA operons (red dots) have
a significant tendency to have lower N3E values when cells are treated with Rif (binomial test, P-value = 0.015). On the other hand, GCSs that fall into
REPs (green dots) reveal tendency to increase N3E under the same conditions (binomial test, P-value = 4e–7).
BIME-2 in consistence with old observations (35) and espe-
cially prefers loops and non-complementary regions within
the stems of cruciform-forming REPs (Supplementary Fig-
ure S10). The number of GCSs-containing REPs within
particular BIME-2 elements considered by Espeli and Boc-
card (36) is also similar to the previously observed number
of gyrase-generated cuts. Thus, DNA gyrase binds at least
some BIME-2s in vivo. BIME-2 locate in intergenic regions
and accumulation of GCSs in them could be due to posi-
tive supercoiling associated with transcription of adjacent
genes. In this case one would expect the gyrase signal to
decrease when transcription is inhibited by Rif: however,
the opposite is observed (Figure 6D). Interestingly, BIME-
2 have a higher mean score than expected (–1.3 versus –2.3
over the E. coli genome; t-test, P-value ∼0), which may be a
reason of their preferential binding by gyrase. Thus, BIME-
2 have properties of transcription-independent strong gy-
rase sites and might contribute to genome organization.
GCSs colocalize with MukB and avoid H-NS binding regions
Nucleoid-associated proteins (NAPs) contribute to genome
organization and local topology. High-resolution maps of
the binding sites of E. coli NAPs Fis, IHF, H-NS, MatP,
and MukB are available (81–83). Genome-wide cleavage
data are also published for E. coli Topo IV, which is a
close paralog of DNA gyrase (49). We compared avail-
able datasets with our Topo-Seq data to find potential as-
sociations between gyrase activity and these proteins. We
found that GCSs are slightly underrepresented at IHF sites
and at Fis sites in Cfx (±Rif) and Oxo treated cells (bino-
mial test, P-value < 0.002) but not in Micro-treated cells.
GCSs are strongly underrepresented at H-NS binding re-
gions (binomial test, P-value < 9.75e–23) for all experimen-
tal conditions (Supplementary Table DS6). H-NS, a well-
known transcription repressor, primarily associates with
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and (82)). Hence, H-NS occupied areas are expected to lack
transcription-mediated positive supercoiling. Sequences of
H-NS occupied areas also score lower than the genome
mean for gyrase motif (–4.4 versus –2.3, t-test P-value ∼0).
A combination of these two factors may jointly contribute
to gyrase avoidance.
Due to similarities in the structure and mechanism of
Topo IV and gyrase, one could expect a correspondence be-
tween their cleavage sites distribution. However, our anal-
ysis did not reveal any significant association, either posi-
tive or negative, between GCSs and Topo IV cleavage sites
(Supplementary Table DS6). Topo IV activity and distribu-
tion within a cell are thought to be positively connected to
MukBEF––a complex involved in structural maintenance
of chromosomes (9). In turn, MukBEF is known to physi-
cally interact with the MatP protein (83). MatP binds with
high affinity to specific matS sites that concentrate in the
Ter macrodomain (84), and displaces the MukBEF com-
plex (83,85). Together, the Topo IV-MukBEF-MatP system
is thought to coordinate the proper timing of replicating
chromosome unlinking and segregation (83). We found that
GCSs are overrepresented at MatP-occupied regions (bino-
mial test, P-value < 0.006) but not in the immediate vicin-
ity of matS sites (Supplementary Table DS6). Strikingly,
the enrichment is even more pronounced for MukB sites
(binomial test, P-value < 3.9e–14) (Supplementary Table
DS6). In fact, the genome-wide MukB distribution is sim-
ilar to that of the gyrase (Supplementary Figure S11) and
MukB accumulates at extended regions downstream of TUs
in transcription-dependent manner (Supplementary Figure
S16C, Supplementary Figure S13C). Moreover, the gyrase
binding motif score of MukB binding regions is relatively
high (–1.5 versus –2.3 genome average, t-test P-value ≈ 0).
Overall, we suggest that DNA gyrase likely acts indepen-
dently of the MatP-MukBEF-TopoIV decatenation ensem-
ble but the MukBEF complex might synergize with the gy-
rase downstream of active TUs by stabilizing plectonemes
induced by transcription-dependent positive supercoiling.
Lack of association between GCSs density, topologically as-
sociated domains (TADs), and sites of spontaneous mutations
DNA-gyrase supercoiling activity might contribute to bac-
terial genome structuring (28,86). We therefore looked for
association of GCSs with TADs, as defined for E. coli
MG1655 (85). However, no significant over- or underrep-
resentation of GCSs were found either in TADs, the inter-
TADs, or nearby the TADs borders (Supplementary Table
DS8). Gyrase sites on DNA can also be expected to have an
increased rate of spontaneous mutations due to association
with double-strand breaks introduced by gyrase. We com-
pared the distribution of spontaneous mutations through-
out the E. coli genome (for wild-type and mutagenic mutL
cells (87)) and found no pronounced associations between
mutations and GCSs (Supplementary Table DS9).
DISCUSSION
In this paper, we used Topo-Seq (drug-induced trapping and
purification of covalent topoisomerase-DNA complexes,
followed by application of a single-strand paired-end se-
quencing protocol) to robustly identify thousands of GCSs
across the genome of E. coli treated with gyrase poisons.
The results provide unprecedented, single-nucleotide pre-
cision view of gyrase localization throughout the chromo-
some. While our data relied on gyrase poisons to trap the
enzyme on DNA, the similarities with ChIP study of gyrase
binding (24) and commonality of genome-wide GCS pat-
terns and binding motifs observed for unrelated inhibitors
strongly suggest that our experiments provide information
about the natural distribution of gyrase along the E. coli
chromosome. This is further supported by the observation
that the common GCS motif revealed by Topo-Seq strongly
binds to the DNA gyrase in vitro in the absence of gyrase
poisons.
We observed a global ori-ter gradient in the frequencies
of GCSs which agrees well with ChIP-ChIP data obtained
in the absence of poisons (24) (Supplementary Figure S15).
The trend can be explained by either gyrase-binding score
gradient (sequences near the origin have higher propensity
to bind gyrase) or by transcription gradient (higher level of
transcription near origin). When transcription is inhibited
by Rif, the ori-ter gradient remains, although it becomes sig-
nificantly less pronounced (Pearson’s correlation between
the number of GCSs and transcription level falls from 0.85
for Cfx dataset to 0.24 for RifCfx set). Thus, it seems that
transcription primarily forms gyrase activity gradient over
the genome by influencing local supercoiling state (Sup-
plementary Figure S11). Gyrase activity might neutralize
transcription-mediated positive supercoiling which leads to
an even distribution of superhelisity over the genome in the
phase of exponential growth as detected by psoralen bind-
ing assay (27).
Identification of thousands of GCSs allowed us to delin-
eate the gyrase binding motif characterized by phased varia-
tion in G/C content. This motif is too long (130 bp) and too
degenerate to be identified by standard algorithms (MEME
(88), ChIP-Munk (89), or Gibbs-sampler (90)). The 130-bp
motif matches the length of DNA protected by the gyrase
from hydroxyl radical cleavage (91). The central 36 bp part
of the motif is contained within a 40–50 bp segment most
strongly protected from DNase I cleavage in in vitro exper-
iments, while the flanking 47-bp periodic regions are likely
localized on the sides. The G/C content variation may be
explained by DNA lying on protein surface in a way that
its minor groove contains GC when open to solution, and
AT when facing the protein. AT-rich tracts are known to
be flexible (92) and tend to form bends when positioned in
phase with DNA helix (93), as observed in the gyrase motif.
The size of a periodic regions agrees well with the 35–52-bp
minimal DNA fragments which are thought to be wrapped
around GyrA CTDs (78) (Figure 7). Our in vitro experi-
ments with DNA sequences having different levels of sim-
ilarity to gyrase motif independently support this conclu-
sion. Well-phased sequences (Mu SGS and consensus) bind
to the gyrase much better than the scrambled one (Figure
5A) and cause the slowing down of enzyme (Figure 5BC).
On the other hand, gyrase lacking CTDs shows no differ-
ences when relaxing different substrates (Figure 5D). That
might mean that very strong binding detected for phased
sequences could interfere with CTD movements crucial for
optimal activity of the enzyme as discussed in (94,95). Inter-
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Figure 7. DNA gyrase binding motif reflects DNA wrapping around the CTDs. DNA gyrase ‘combined’ motif (based on datasets from all three different
antibiotics tested) flanked with random regions shown in green. Orange arrows indicate GC-rich and hydroxyl radical hypersensitive sites, blue arrows––AT-
rich and protected regions. The structure of DNA-wrapped CTD is shown above the motif, dashed arrows point hypersensitive sites in DNA’s minor groove.
MaG––DNA major groove, MiG––DNA minor groove. Hydroxyl radical sensitivity data is taken from (91).
for the pSC101 SGS (46), which we identified as a high-
scoring sequence (score = 16), that might explain why there
are no sequences in E. coli genome with a score higher than
∼15.
GCSs sets obtained with cells treated by different drugs
overlapped only partially, which likely results from spe-
cific drug–DNA interactions in the central part of the mo-
tif at the cleavage site. Interestingly, Micro GCSs have
weaker cleavage pattern compared to those obtained with
quinolone drugs (Figure 4B). This may indicate that Mi-
cro does not intercalate into DNA with its oxazole/thiazole
regions, and instead traps gyrase differently. This notion
is consistent with an observation that the periodic part of
Micro motif has the highest amplitude, possible reflecting
periodic interaction of Micro oxazole/thiazole cycles with
DNA bound to CTDs. Intriguingly, it’s been shown previ-
ously that long DNA segments and strand passage are es-
sential for Micro to form a stable cleavage complex (76).
Transcription-induced positive supercoiling is a well-
known factor that attracts gyrase activity (21,23,24). Our
data show that more DNA gyrase is associated with ex-
tended (∼2–5 kb) regions downstream of actively tran-
scribed transcription units (Supplementary Figure S13).
While such association is predicted by the Wang model, our
results show that gyrase concentrates not directly in front of
the elongating RNA polymerase but much further down-
stream of in vivo transcription termination sites (as deter-
mined in (96)), including areas of poorly transcribed down-
stream genes (Supplementary Figure S13D). Interestingly,
attraction of gyrase to these downstream regions seems not
to be hard-wired in the genome, since the gyrase motif
scores of GCSs in downstream regions and scores of these
regions themselves are the same or lower that throughout
the rest of the genome (Supplementary Table DS 7B). The
result underscores the driving role of transcription in pop-
ulating these sites by the gyrase and explains the redistribu-
tion of gyrase observed upon transcription inhibition.
It appears that sequence properties and transcription are
not the sole factors regulating gyrase activity. For exam-
ple, some high-scoring sites are not GCSs and genome-wide
correlation between gyrase binding score and N3E value
does not rise significantly for Rif-treated cells, as could have
been expected. No data are available for E. coli enzyme in-
teractions with nucleoid structuring proteins, however local
topology of nucleic acid modulated by them might influence
gyrase behavior in a complicated way. Recently, for exam-
ple, GapR protein was found in Caulobacter crescentus, that
specifically interacts with positively supercoiled DNA and
stimulates gyrase and Topo IV activity, possibly via interac-
tion with them (97). To support this notion, we found sta-
tistically significant associations of gyrase sites with bind-
ing regions of several NAPs. While regions of H-NS and
MukB binding shows strong associations with sites of gy-
rase activity (negative and positive respectively), link with
other proteins is less pronounced. Negative correlation with
IHF-occupied sites cannot be explained either by the dis-
tribution of the protein across the genome - like gyrase,
IHF is more presented at Ori and less at Ter (Supplemen-
tary Figure S11H), or by association with silent genes - we
did not find any transcription-dependent binding for IHF
(Supplementary Figure S16B). Also, it is not based on se-
quence properties of IHF sites as their mean score is close
to genome mean (–2.4 versus –2.3). Another weak negative
association was found with Fis. It is known to bind in up-
stream regions of TUs (82) and we noticed that this effect
is transcription-dependent (Supplementary Figure S16A).
Score of Fis sites is just a little lower than genome mean
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act on different sides of TUs. It should be noted, however,
that Fis is a repressor of transcription of both the gyrA and
gyrB genes in E. coli and Salmonella (98), while fis transcrip-
tion itself is stimulated by high levels of negative supercoil-
ing (99).
It is more difficult to explain a positive association be-
tween GCSs and MatP sites which exists only for non-
Ter and at the same time weak (<3-fold enrichment) sites
(Supplementary Table DS6). In contrast, all Ter sites show
mainly negative association with GCSs, while strong (>3-
fold MatP enrichment) and non-Ter regions lack any asso-
ciations. We can explain this by binding between MukBEF
and MatP, that results in a colocalization of binding sites
(Fisher exact test, P-value = 6.27e–17) (Supplementary Ta-
ble DS6A). This hypothesis still needs to be tested experi-
mentally.
Global transcriptional responses to environmental fac-
tors can be mediated by supercoiling via gyrase or other
topoisomerases (1,100,101). Use of trapping agents to
catch the enzymes in flagrante delicto on a nucleic acid
is a promising alternative for non-specific formaldehyde-
mediated ChIP-Seq approaches (49,50). The combination
of a specific sequencing protocol with a cleavage pattern
detecting algorithm results in single-nucleotide precision of
Topo-Seq. Our method can be directly applied to differ-
ent bacteria including pathogens such as Salmonella or My-
cobacteria, whose global supercoiling dynamics must be sig-
nificantly different from that of E. coli (102,103), and to
Caulobacter crescentus and genome-reduced Mycoplasma,
in which supercoiling was shown to contribute to chromo-
somal domain organization (104,105). The Cfx-sensitive gy-
rase is found in eukaryotes such as plants and Apicom-
plexa (106–108). The yet-unknown function of the enzyme
in these organisms can be assessed using Topo-Seq. Finally,
our method can be easily modified to study a larger variety
of enzymes (other topoisomerases, recombinases etc.) that
form intermediate covalent complexes with nucleic acids in
the presence of stabilizing poisons.
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